3 Cheap TSX Stocks to Buy Before a Santa Claus Rally

Last-minute shoppers should have these three discounted TSX stocks on their watch lists this holiday season.

| More on:
Arrowings ascending on a chalkboard

Image source: Getty Images.

With the market up close to 20% in 2021, it’s definitely been a good year to be invested in TSX stocks. Even amid a global pandemic that continues to wreak havoc, many Canadian companies have soared to all-time highs.

The new COVID variant has put a minor dent in the memorable year for Canadian investors. Since early November, the market has now dropped more than 5%.   

The market’s selloff has been well timed for anyone planning on doing some last-minute holiday shopping. Canadian investors have not had many buying opportunities this year, but right now is certainly one of them. 

If you’re still missing a few gifts, do your portfolio a favour and pick up some shares of at least one of these three discounted TSX stocks.

Nuvei

Nuvei (TSX:NVEI)(NASDAQ:NVEI) had an incredibly impressive first year as a public company. After joining the TSX in September 2020, the tech stock was up more than 250% just 12 months later. Fast forward three months, and shares are now down 60% from all-time highs.

The payments company had a whirlwind first year trading on the public market. But considering the TSX stock’s valuation, the volatility that investors have witnessed over the past three months should not be all that surprising.

A short report was the main culprit for the tech stock’s recent selloff. The report contained serious allegations questioning management’s integrity and the company’s long-term growth potential. Both of which I’d largely disagree with.

If you were bullish on Nuvei before this report was released, I’d highly suggest taking advantage of this discounted price. As a massive bull on the payments space, Nuvei is definitely on my radar now that it’s trading at a much more reasonable valuation. 

WELL Health Technologies

Another industry I’m bullish on is telemedicine. Unsurprisingly, telemedicine stocks surged at the beginning of the pandemic, as demand for virtual health appointments skyrocketed. 

But now that we’re also two years into dealing with this pandemic, demand for telemedicine services has largely declined. As a result, many leaders in the sector are trading well below all-time highs.   

Shares of WELL Health Technologies (TSX:WELL) were up a market-crushing 400% in 2020. In 2021, though, the TSX stock is down close to 40%. 

A loss of that magnitude is not all that surprising after putting up a four-bagger in the year prior. The stock is likely correcting itself after a year of very abnormal growth.

Investing in a stock down 40% on the year is not something I’d suggest to short-term investors. But if you’re got a time horizon of five years or longer, WELL Health is hard to ignore at these prices. In five years’ time, I’d be confident betting that the TSX stock will have returned to delivering market-crushing gains. 

Northland Power

Last on my list is another market-leading stock in a sector that has had a rough year. Many renewable energy stocks have not only trailed the market’s returns this year but are also trading at losses. 

Shares of Northland Power (TSX:NPI) are down almost 20% year to date. Still, the TSX stock is up a market-beating 60% over the past five years. And that’s not even factoring in the company’s impressive 3% dividend yield. 

Renewable energy is another area of the market I’d urge any long-term investor to have exposure to. And now’s an opportunistic time to go shopping with many high-quality companies trading at significant discounts.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Nicholas Dobroruka has no position in any of the stocks mentioned. The Motley Fool owns and recommends Nuvei Corporation.

More on Investing

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Woman has an idea
Investing

3 No-Brainer Stocks to Buy With $200 Right Now

These three stocks are no-brainer buys, given their solid underlying businesses and healthy growth prospects.

Read more »

Investing

2 Stocks I’m Loading Up on in 2024

Alimentation Couche-Tard (TSX:ATD) and another stock that are getting too cheap after their latest corrections.

Read more »

grow money, wealth build
Dividend Stocks

1 Top Dividend Stock That Can Handle Any Kind of Market (Even Corrections)

While most dividend aristocrats can maintain their payouts during weak markets, very few can maintain a healthy valuation or bounce…

Read more »

Red siren flashing
Dividend Stocks

Income Alert: These Stocks Just Raised Their Dividends

Three established dividend-payers from different sectors are compelling investment opportunities for income-focused investors.

Read more »

online shopping
Tech Stocks

1 Hidden Catalyst That Could Ignite Shopify Stock

Here's why Shopify (TSX:SHOP) ought to remain a top growth stock investors continue to focus on for the long haul.

Read more »

Oil pumps against sunset
Energy Stocks

Is it Too Late to Buy Enbridge Stock?

Besides its juicy and sustainable dividends, Enbridge’s improving long-term growth prospects make it a reliable stock to hold for the…

Read more »

Man considering whether to sell or buy
Tech Stocks

WELL Stock: Buy, Sell, or Hold?

WELL stock has a lot of upside as the company is likely to continue to grow, posting positive earnings in…

Read more »